As we are targeting an industry-ready solution after piloting in real-life settings, we have opted for the second option.
Limitations: When a new chronic disease is to be addressed within our platform, reconciliation rules covering all disease combinations have to be re-assessed by the clinical expert group.
Suggestions for future research: Fully-automated reconciliation approaches need to be further studied and validated in real-life settings.
Keywords: personalised care plan; clinical guidelines; multi-morbidity; clinical decision support; patient empowerment
